BIOCON.BOBIOCON.BOBSE
Loading
Operating Income PerformanceStrong
Percentile Rank93
3Y CAGR+33.0%
5Y CAGR+23.4%
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

3Y CAGR
+33.0%/yr
vs +14.5%/yr prior
5Y CAGR
+23.4%/yr
Recent acceleration
Acceleration
+18.5pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$47.20B-7.1%
2024$50.83B+52.6%
2023$33.30B+66.1%
2022$20.04B-22.8%
2021$25.98B+57.2%
2020$16.52B-17.4%
2019$19.99B+71.5%
2018$11.66B-9.3%
2017$12.86B+23.9%
2016$10.38B-